Vecihe Bayrak

Vecihe Bayrak

Auto-generated profile, based on publicly available information

Vecihe Bayrak

Department of Internal Medicine, Division of Intensive Care Medicine, Dokuz Eylul University Faculty of Medicine, Izmir, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
VBVecihe Bayrak
Vecihe Bayrak
NDNurcan Şentürk Durukan
Nurcan Şentürk Durukan
FAFerhan Demirer Aydemir
Ferhan Demirer Aydemir
BEBegüm Ergan
Begüm Ergan
NGNaciye Sinem Gezer
Naciye Sinem Gezer
YSYusuf Savran
Yusuf Savran
Coronavirus disease 2019 (COVID-19) is a disease with a high rate of progression to critical illness. However, the predictors of mortality in critically ill patients admitted to the intensive care unit (ICU) are not yet well understood. In this study, we aimed to investigate the risk factors associated with ICU mortality in our hospital. In this single-centered retrospective study, we enrolled 86 critically ill adult patients with COVID-19 admitted to ICU of Dokuz Eylul University Hospital (Izmir, Turkey) between 18 March 2020 and 31 October 2020. Data on demographic information, preexisting comorbidities, treatments, the laboratory findings at ICU admission and clinical outcomes were collected. The chest computerized tomography (CT) of the patients were evaluated specifically for COVID-19 and CT score was calculated. Data of the survivors and nonsurvivors were compared with survival analysis to identify risk factors of mortality in the ICU. The mean age of the patients was 71.1±14.1 years. The patients were predominantly male. The most common comorbidity in patients was hypertension. ICU mortality was 62.8%. Being over 60 years old, CT score > 15, acute physiology and chronic health evaluation (APACHE) II score ? 15, having dementia, treatment without favipiravir, base excess in blood gas analysis ? -2.0, WBC > 10000/mm³, D-dimer > 1.6 ug/mL, troponin > 24 ng/L, Na ? 145 mmol/L were considered to link with ICU mortality according to Kaplan-Meier curves (log-rank test, p<0.05). APACHE II score (HR:1.055, 95%CI: 1.021-1.090) and chest CT score (HR:2.411, 95%CI:1.193-4.875) were associated with ICU mortality in the cox proportional-hazard regression model adjusted for age, dementia, favipiravir treatment and troponin. Howewer, no difference was found between survivors and nonsurvivors in terms of intubation timing. COVID-19 patients have a high ICU admission and mortality rate. Studies in the ICU are also crucial in this respect. In our study, we investigated the ICU mortality risk factors of COVID-19 patients. We determined a predictive mortality model consisting of APACHE II score and chest CT score. It was thought that this feasible and practical model would assist in making clinical decisions.

19 June 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SYSüleyman Yıldırım
Süleyman Yıldırım
EEErdem Erkoyun
Erdem Erkoyun
ÖAÖzcan Alpdoğan
Özcan Alpdoğan
HYHüseyin Oğuz Yılmaz
Hüseyin Oğuz Yılmaz
BYBarış Yılmaz
Barış Yılmaz
CKCenk Kirakli
Cenk Kirakli

11 October 2025 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
FAFerhan Demirer Aydemir
Ferhan Demirer Aydemir
ÖKÖzge Kurtlu
Özge Kurtlu
BEBişar Ergün
Bişar Ergün
VBVecihe Bayrak
Vecihe Bayrak
OOOzlem Oner
Ozlem Oner
VHVolkan Hanci
Volkan Hanci
Delays in intensive care unit (ICU) admissions are prevalent in overcrowded hospitals and can adversely affect patient outcomes. However, the extent of this impact, particularly beyond short-term mortality, remains unclear. We hypothesized that ICU admission delays exceeding 6 hours after consultation would independently increase 90-day mortality and prolong ICU length of stay. We conducted a retrospective analysis of data from 273 adult patients admitted to the ICU of a tertiary university hospital between January and December 2019. Patients were stratified into two groups: early admission (≤6 hours) and delayed admission (>6 hours). Multivariate Cox regression was employed to identify independent predictors of mortality. Delayed ICU admission was observed in 72.8% of patients. Although delayed admission was not independently associated with increased mortality in the multivariate analysis (HR: 0.88; 95% CI: 0.61–1.27), it was significantly correlated with prolonged ICU length of stay and higher 90-day mortality in the univariate analysis (p = 0.039), with no significant difference in vasopressor-free days (p = 0.809). In our assessment of independent mortality predictors, we found that patients with higher APACHE-II and Charlson scores experienced longer delays in ICU transfer. Additionally, respiratory and circulatory failure at admission were independently associated with increased mortality (HR: 2.17; 95% CI: 1.51–3.12). While early ICU admission did not independently predict mortality, it was linked to extended ICU stays, an increased treatment burden, and adverse long-term outcomes. These findings underscore the necessity of refining triage processes and evaluating baseline patient severity when interpreting the impact of ICU admission timing on outcomes.

15 August 2023 in Thoracic Research and Practice
Verified
Journal Article
Open access
BEBişar Ergün
Bişar Ergün
MKMurat Kucuk
Murat Kucuk
MYMehmet Nuri Yakar
Mehmet Nuri Yakar
MOMehmet Celal Ozturk
Mehmet Celal Ozturk
VBVecihe Bayrak
Vecihe Bayrak
BEBegum Ergan
Begum Ergan
Pleural effusion,complicated parapneumonic pleural effusion,pleural fluid lactate,critical illness

1 January 2023 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
VBVecihe Bayrak
Vecihe Bayrak
Bayrak V. Clin Exp Vaccine Res. 2023 Apr;12(2):172-175. https://doi.org/10.7774/cevr.2023.12.2.172

14 March 2025 in Dicle Tıp Dergisi
Verified
Journal Article
Open access
PDF file
VBVecihe Bayrak
Vecihe Bayrak
MGMehmet Çağatay Gürkök
Mehmet Çağatay Gürkök
CACihan Ağalar
Cihan Ağalar
TUTarkan Unek
Tarkan Unek
FAFerhan Demirer Aydemir
Ferhan Demirer Aydemir
NGNecati Gökmen
Necati Gökmen
Aim: Our study aims to investigate the effect of the LMR value on the 30-day mortality and intensive care hospitalization days of post-transplant liver patients without hepatocellular cancer(HCC) admitted to the intensive care unit(ICU). Methods: Our retrospective study included post-liver transplant patients in the ICU of Dokuz Eylul University Hospital between 2010 and 2020. We recorded patients' age, gender, aetiology of liver disease, donor type (living or deceased), duration of cold ischemia, scores, hospitalization days in the ICU, and 30-day mortality. LMR was calculated by dividing the patient's lymphocyte count by the monocyte count. Statistical analyses were performed using SPSS software version 24.0. Results: 128 (92 male, 36 female) patients were included in our study. Twenty-four patients died within 30 days. The mean LMR was 1.498±2.134, and no significant difference existed between those with and without 30-day mortality (p=0.995). LMR value was not a predictor of mortality and ICU hospitalization days in these patients. Conclusion: Our study revealed that LMR does not predict mortality or hospitalization days in post-liver transplant patients without HCC. The results of our study and previous studies suggest that LMR alteration is associated with an immune state produced by the tumour microenvironment. Our findings suggest that LMR may not be a valuable biomarker for predicting patient outcomes in post-liver transplant patients without HCC. However, this study provides a starting point for further investigation into the role of LMR in cancer diseases.